Fund Holdings — Vantage Consulting Group Inc

Total Portfolio Value
$5.02M
Total Bought
$0
Total Sold
$1.55M
Net Transaction
-$1.55M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Fibrogen, Inc195,707195,7070104611.21%-43
ADC Therapeutics SA(ADCT)850,737850,73701,6931,20023.88%-493
Cibus, Inc.(CBUS)1,143,9491,143,94903,1802,13942.58%-1,041
Potbelly Corporation164,8750-164,8751,5530—-1,553
Babcock & Wilcox Enterprises Inc.(BW)2,416,2002,416,20003,9631,62532.34%-2,338
Page 1 of 1
Vantage Consulting Group Inc — 13F Holdings — Q1 2025 | TickerTrail